Royal Bank of Canada
CLVS

Royal Bank of Canada’s Clovis Oncology, Inc. CLVS Stock Holding History

Royal Bank of Canada’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-50,000
Closed -$1.75M – 6756
2015
Q4 		$1.75M Buy
+50,000
New +$3.22M ﹤0.01% 2654

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Royal Bank of Canada's CLVS Position: Q4 2022 in Review

Royal Bank of Canada sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 459,299 shares — an estimated $547K sold.

Royal Bank of Canada first reported a position in CLVS in Q3 2013 and held it in 37 quarters. The position peaked at $9.74M in Q1 2018. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Royal Bank of Canada reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 459,299 Clovis Oncology, Inc. shares in Q4 2022, an estimated $547K.
  • Royal Bank of Canada first reported a position in Clovis Oncology, Inc. in Q3 2013 and held it in 37 quarters.
  • Royal Bank of Canada's Clovis Oncology, Inc. position peaked at $9.74M in Q1 2018.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Royal Bank of Canada's 13F filing for Q4 2022, filed 14 Feb 2023.